F-star Therapeutics, Inc.
F-star Therapeutics, Inc. (FSTX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · FSTX · as of Jun 9, 2026
Key Statistics
Explore F-star Therapeutics, Inc. Data
fstx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 5 · Buy rate: 60.0%
Competitors & Peers
fstx competitorsFSTX
ATYR
DBTX
EXOZ
NGM
PRDSStock Performance
Full HistoryAbout F-star Therapeutics, Inc.
F-star Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to inventing tetravalent bispecific antibodies for the treatment of cancer, particularly within the field of immuno-oncol…
what is f-star therapeutics, inc. · fstx stock overview · f-star therapeutics, inc. company profile · who is f-star therapeutics, inc. ceo · fstx NASDAQ · f-star therapeutics, inc. headquarters · f-star therapeutics, inc. business segments
About Stock Overview & Key Data
F-star Therapeutics, Inc. (FSTX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since May 7, 2021. As of the latest trading session, FSTX stock price is $7.12, with a market capitalization of $156.5M. The stock has returned +100.00% over the past 12 months and +15.40% year-to-date.
According to 5 Wall Street analysts, the consensus rating for F-star Therapeutics, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2021, F-star Therapeutics, Inc. reported revenue of $21.2M and net income of -$31.3M. For detailed data — including F-star Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, F-star Therapeutics, Inc. (FSTX) stock price is $7.12. The stock is traded on NASDAQ under the ticker symbol FSTX. The 52-week range is $2.07 – $7.12.